Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Lung Cancer

Free Subscription Articles published in Eur J Cardiothorac Surg Retrieve available abstracts of 243 articles: HTML format

Single Articles

November 2024
1. LUO X, Hayanga JWA, Mehaffey JH, Lamb J, et al
   Clinical stage IA non-small cell lung cancer with occult pathologic N1 and N2 disease after segmentectomy: does a completion lobectomy justify?
   Eur J Cardiothorac Surg. 2024 Nov 19:ezae415. doi: 10.1093.
   PubMed     Abstract available
   
   
   
2. GOMEZ-HERNANDEZ MT, Forcada C, Gomez F, Iscan M, et al
   Early outcomes of robotic versus video-thoracoscopic anatomical segmentectomy: a propensity score-matched real-world study.
   Eur J Cardiothorac Surg. 2024;66:ezae389.
   PubMed     Abstract available
   
   
   
3. LULA LJ, Costa R, Rushwan A, Barreda CF, et al
   European multicentre study evaluating the prognosis of peripheral early-stage lung adenocarcinoma patients operated on by segmentectomy or lobectomy.
   Eur J Cardiothorac Surg. 2024;66:ezae388.
   PubMed     Abstract available
   
   
   
4. BRUNELLI A, Antonoff MB, Petersen RH, Stiles BM, et al
   Surgeon preferences for self-treatment in locally advanced non-small cell lung cancer: Would we practice what we preach?
   Eur J Cardiothorac Surg. 2024;66:ezae344.
   PubMed    
   
   
   
5. GALLINA FT, Cecere FL, Taje R, Bertolaccini L, et al
   Predictive and prognostic factors in patients with anaplastic lymphoma kinase rearranged early-stage lung adenocarcinoma.
   Eur J Cardiothorac Surg. 2024;66:ezae406.
   PubMed     Abstract available
   
   
   October 2024
6. TANG WZ, Xu WZ, Liu TH
   Comparing sleeve lobectomy and pneumonectomy outcomes in non-small cell lung cancer post-neoadjuvant therapy.
   Eur J Cardiothorac Surg. 2024 Oct 9:ezae371. doi: 10.1093.
   PubMed    
   
   
   
7. BERTOLACCINI L, Abu Akar F, Aigner C, Brunelli A, et al
   Optimal planning and management strategies for minimally invasive lung segmentectomies: an international Delphi consensus report.
   Eur J Cardiothorac Surg. 2024;66:ezae351.
   PubMed     Abstract available
   
   
   
8. HOJSKI A, Kramer M, Gecas P, Djakovic Z, et al
   The efficacy of loco-regional ropivacaine analgesia via intercostal catheters after lung resection: a randomized, double-blind, placebo-controlled, superiority study.
   Eur J Cardiothorac Surg. 2024;66:ezae342.
   PubMed     Abstract available
   
   
   
9. HUANG L, Kehlet H, Petersen RH
   Why do patients stay in hospital after enhanced recovery thoracoscopic wedge resection? A prospective observational study.
   Eur J Cardiothorac Surg. 2024;66:ezae366.
   PubMed     Abstract available
   
   
   September 2024
10. SHIONO S, Endo M, Watanabe H, Takamori S, et al
    Better survival with lobectomy versus. sublobar resection in patients with hypermetabolic c-stage IA lung cancer on positron emission tomography/computed tomography.
    Eur J Cardiothorac Surg. 2024 Sep 25:ezae347. doi: 10.1093.
    PubMed     Abstract available
    
    
    
11. ZHANG M, Yan M, Xiao Z, Li Y, et al
    Exploring clinical factors to predict the survival for resectable non-small cell lung cancer patients with neoadjuvant immunotherapy.
    Eur J Cardiothorac Surg. 2024 Sep 13:ezae335. doi: 10.1093.
    PubMed     Abstract available
    
    
    
12. LEE JO, Lee GD, Choi S, Kim HR, et al
    Surgical prognosis of lung invasive mucinous and non-mucinous adenocarcinoma: propensity score matched analysis.
    Eur J Cardiothorac Surg. 2024;66:ezae316.
    PubMed     Abstract available
    
    
    
13. SHEN X, Zhao M, Deng J, Chen T, et al
    Long-term prognostic characteristics of patients with clinical stage IA part-solid lung adenocarcinoma: a conditional survival analysis.
    Eur J Cardiothorac Surg. 2024;66:ezae337.
    PubMed     Abstract available
    
    
    August 2024
14. TENG M, Yi C, Yang W, Zhang J, et al
    Sleeve lobectomy versus pneumonectomy following neoadjuvant therapy in patients with non-small cell lung cancer.
    Eur J Cardiothorac Surg. 2024 Aug 9:ezae300. doi: 10.1093.
    PubMed     Abstract available
    
    
    
15. MA Y, Fei X, Jiang C, Chen H, et al
    Lung adenocarcinoma manifested as ground-glass nodules in teenagers: characteristics, surgical outcomes and management strategies.
    Eur J Cardiothorac Surg. 2024;66:ezae291.
    PubMed     Abstract available
    
    
    July 2024
16. POULLIS M
    Pulmonary metastasectomy-back to basic biology.
    Eur J Cardiothorac Surg. 2024;66:ezae272.
    PubMed    
    
    
    
17. TREASURE T, Macbeth F, Fallowfield L
    Reply to Michael Poullis about lung metastasectomy.
    Eur J Cardiothorac Surg. 2024;66:ezae274.
    PubMed    
    
    
    
18. LANGERON M, Khen-Dunlop N, Helfre S, Sarnacki S, et al
    Efficacy of an expandable prosthesis placement after left pneumonectomy for soft tissue Ewing sarcoma in a 5-year-old child: 10 years follow-up.
    Eur J Cardiothorac Surg. 2024;66:ezae259.
    PubMed     Abstract available
    
    
    
19. PRISCIANDARO E, Ceulemans LJ, Van Raemdonck DE, Spaggiari L, et al
    Pulmonary metastasectomy gaining ground in modern thoracic surgery.
    Eur J Cardiothorac Surg. 2024;66:ezae281.
    PubMed    
    
    
    
20. CHEN K, Niu Z, Jin R, Nie Q, et al
    Three-dimensional reconstruction computed tomography in thoracoscopic segmentectomy: a randomized controlled trial.
    Eur J Cardiothorac Surg. 2024;66:ezae250.
    PubMed     Abstract available
    
    
    June 2024
21. ALEXANDRE THOMAS P, Seguin-Givelet A, Pages PB, Alifano M, et al
    Real-world outcomes of lobectomy, segmentectomy, and wedge resection for the treatment of stage c-IA lung carcinoma.
    Eur J Cardiothorac Surg. 2024 Jun 25:ezae251. doi: 10.1093.
    PubMed     Abstract available
    
    
    
22. TREASURE T, Macbeth F, Fallowfield L
    A prospective multicentre cohort study of colorectal lung metastasectomy with a nested randomized controlled trial: the key points from the pulmonary metastasectomy in colorectal cancer study.
    Eur J Cardiothorac Surg. 2024;65:ezae216.
    PubMed    
    
    
    
23. RODRIGUEZ-FUSTER A, Diaz-Ravetllat V
    Multicentre retrospective analysis on pulmonary metastasectomy: a European perspective.
    Eur J Cardiothorac Surg. 2024;65:ezae224.
    PubMed    
    
    
    
24. MAYER N, Kestenholz P, Minervini F
    Resecting less, breathing better?
    Eur J Cardiothorac Surg. 2024;65:ezae233.
    PubMed    
    
    
    
25. PFEUTY K, Rojas D, Iquille J, Lenot B, et al
    Postoperative day 1 discharge following subxiphoid thoracoscopic anatomical lung resection: a single-centre, postoperative enhanced recovery experience.
    Eur J Cardiothorac Surg. 2024;65:ezae230.
    PubMed     Abstract available
    
    
    May 2024
26. WERNER RS, Rechsteiner M, Moch H, Curioni-Fontecedro A, et al
    Genetic profiles of oligometastatic non-small cell lung cancer and corresponding brain metastases.
    Eur J Cardiothorac Surg. 2024 May 25:ezae217. doi: 10.1093.
    PubMed     Abstract available
    
    
    
27. BRUNELLI A, Tariq J, Mittal A, Lodhia J, et al
    Self-reported dyspnoea and shortness of breathing deterioration in long-term survivors after segmentectomy or lobectomy for early-stage lung cancer.
    Eur J Cardiothorac Surg. 2024 May 15:ezae200. doi: 10.1093.
    PubMed     Abstract available
    
    
    
28. LEE M, Santhirakumaran G, Waller D, Elkhouly A, et al
    The use of diagnostic complex robotic-assisted segmentectomy in the management of incidental and screen-detected pulmonary nodules.
    Eur J Cardiothorac Surg. 2024;65:ezae139.
    PubMed     Abstract available
    
    
    
29. PROVOOST AL, Bouckaert A, Vanluyten C, Barbarossa A, et al
    Aerostasis to limit air leak following extended pleurectomy-decortication.
    Eur J Cardiothorac Surg. 2024;65:ezae181.
    PubMed     Abstract available
    
    
    
30. 
    Corrigendum to: Minimally invasive surgery for clinical T4 non-small-cell lung cancer: national trends and outcomes; Is underutilization of adjuvant therapy in resected non-small-cell lung cancer associated with socioeconomic disparities?; and Subloba
    Eur J Cardiothorac Surg. 2024;65:ezae203.
    PubMed    
    
    
    
31. LI K, Li B, Yang J
    Optimal lymphadenectomy should be based on number or location or both?
    Eur J Cardiothorac Surg. 2024;65:ezae190.
    PubMed    
    
    
    April 2024
32. SAKURAI H, Goto Y, Yoh K, Takamochi K, et al
    Prognostic significance of ground-glass areas within tumors in non-small cell lung cancer.
    Eur J Cardiothorac Surg. 2024 Apr 10:ezae158. doi: 10.1093.
    PubMed     Abstract available
    
    
    
33. UEDA T, Takamochi K, Fukui M, Ichikawa T, et al
    Significance of preoperative exercise oxygen desaturation in lung cancer with interstitial lung disease.
    Eur J Cardiothorac Surg. 2024 Apr 10:ezae142. doi: 10.1093.
    PubMed     Abstract available
    
    
    
34. CHARLOUX A, Olland A, Falcoz PE
    Minute ventilation to carbon dioxide slope and risk stratification before lung cancer resection.
    Eur J Cardiothorac Surg. 2024 Apr 5:ezad390. doi: 10.1093.
    PubMed    
    
    
    
35. LAMPRIDIS S
    Optimising care in obese lung cancer patients undergoing lobectomy: Analysing complications by surgical approach.
    Eur J Cardiothorac Surg. 2024 Apr 1:ezae129. doi: 10.1093.
    PubMed    
    
    
    March 2024
36. CHEN T, Wen J, He Y, Zhong Y, et al
    Neoadjuvant chemoimmunotherapy confers survival advantage for patients undergoing sleeve lobectomy.
    Eur J Cardiothorac Surg. 2024;65:ezae125.
    PubMed     Abstract available
    
    
    
37. BRUNELLI A
    Segmentectomy: lower surgical quality is associated with poorer outcomes.
    Eur J Cardiothorac Surg. 2024;65:ezae144.
    PubMed    
    
    
    
38. SACHS E, Jackson V, Al-Ameri M, Sartipy U, et al
    Uniportal video-assisted thoracic surgery: segmentectomy versus lobectomy-early outcomes.
    Eur J Cardiothorac Surg. 2024;65:ezae127.
    PubMed     Abstract available
    
    
    
39. PRISCIANDARO E, Bertolaccini L, Fieuws S, Cara A, et al
    Multicentre retrospective analysis on pulmonary metastasectomy: an European perspective.
    Eur J Cardiothorac Surg. 2024;65:ezae141.
    PubMed     Abstract available
    
    
    
40. HENSCHKE P, Guglielmetti LC, Hillinger S, Monsch GM, et al
    Risk factors influencing postoperative pleural empyema in patients with pleural mesothelioma: a retrospective single-centre analysis.
    Eur J Cardiothorac Surg. 2024;65:ezae137.
    PubMed     Abstract available
    
    
    
41. TIAN Y, Liu Z, Pan H, Zhu H, et al
    Perioperative immune checkpoint blockades improve prognosis of resectable non-small cell lung cancer.
    Eur J Cardiothorac Surg. 2024 Mar 26:ezae110. doi: 10.1093.
    PubMed     Abstract available
    
    
    
42. SINGH A, Mazzola E, Xie Y, Marshall MB, et al
    Lung cancer outcomes in the elderly: Potential disparity in screening.
    Eur J Cardiothorac Surg. 2024 Mar 5:ezae080. doi: 10.1093.
    PubMed     Abstract available
    
    
    
43. BONGIOLATTI S, Gonfiotti A, Salvicchi A, Voltolini L, et al
    The role of minimally invasive surgery on cT4 tumours: still many unanswered question.
    Eur J Cardiothorac Surg. 2024;65:ezae049.
    PubMed    
    
    
    
44. MIURA K, Ide S, Minamisawa M, Mishima S, et al
    Sublobar resection or lobectomy and postoperative respiratory complications in emphysematous lungs.
    Eur J Cardiothorac Surg. 2024;65:ezae061.
    PubMed     Abstract available
    
    
    
45. BACIEWICZ FA JR
    'The Nodes Always Know'!
    Eur J Cardiothorac Surg. 2024;65:ezae102.
    PubMed    
    
    
    
46. MCALLISTER MA, Rochefort MM, Ugalde Figueroa P, Leo R, et al
    Complete anatomic segmentectomy shows improved oncologic outcomes compared to incomplete anatomic segmentectomy.
    Eur J Cardiothorac Surg. 2024;65:ezae089.
    PubMed     Abstract available
    
    
    
47. WANG S, Bao X, Yang F, Shi H, et al
    Multiparametric evaluation of mediastinal lymph node metastases in clinical T0-T1c stage non-small-cell lung cancers.
    Eur J Cardiothorac Surg. 2024;65:ezae059.
    PubMed     Abstract available
    
    
    February 2024
48. WANG RR, Li MJ, Peng Q, Huang ZY, et al
    Validation of the ninth edition of the TNM staging system for Non-Small cell lung cancer with lobectomy in stage IA-IIIA.
    Eur J Cardiothorac Surg. 2024 Feb 29:ezae071. doi: 10.1093.
    PubMed     Abstract available
    
    
    
49. GONZALEZ M, Ojanguren A, Figueroa S, Bedat B, et al
    Segmentectomy for lung cancer: Dig deeper.
    Eur J Cardiothorac Surg. 2024 Feb 24:ezae066. doi: 10.1093.
    PubMed    
    
    
    
50. BERNARDI E, Diotti C, Bertolaccini L, Donghi S, et al
    Mediastinal cellulose pack mimicking lung cancer relapsing after lobectomy.
    Eur J Cardiothorac Surg. 2024 Feb 23:ezae065. doi: 10.1093.
    PubMed    
    
    
    
51. MATSUI T, Takahashi Y, Nakada T, Sugita Y, et al
    Impact of intrapulmonary tumor location of non-small cell lung cancer on surgical outcomes for segmentectomy.
    Eur J Cardiothorac Surg. 2024 Feb 3:ezae036. doi: 10.1093.
    PubMed     Abstract available
    
    
    
52. BRUNELLI A, Decaluwe H, Gonzalez M, Gossot D, et al
    Which extent of surgical resection thoracic surgeons would choose if they were diagnosed with an early-stage lung cancer: a European survey.
    Eur J Cardiothorac Surg. 2024;65:ezae015.
    PubMed    
    
    
    
53. SOLDATH P, Binderup T, Kjaer A, Knigge U, et al
    Prognostic thresholds of fluorine-18 fluorodeoxyglucose-positron emission tomography mean and maximum standardized uptake values for survival and nodal involvement in lung neuroendocrine neoplasms.
    Eur J Cardiothorac Surg. 2024;65:ezae030.
    PubMed     Abstract available
    
    
    
54. BARCELOS RR, Sugarbaker E, Kennedy KF, McAllister M, et al
    Time between imaging and surgery is not a risk factor for upstaging of clinical stage IA non-small-cell lung cancer.
    Eur J Cardiothorac Surg. 2024;65:ezae057.
    PubMed     Abstract available
    
    
    January 2024
55. RODRIGUEZ-QUINTERO JH, Elbahrawy MM, Montal AM, Jindani R, et al
    "Minimally invasive surgery for clinical T4 Non-Small cell lung cancer: National trends and outcomes".
    Eur J Cardiothorac Surg. 2024 Jan 23:ezae009. doi: 10.1093.
    PubMed     Abstract available
    
    
    
56. PLANAS-CANOVAS G, Belda-Sanchis J, Martinez-Tellez E, Trujillo-Reyes JC, et al
    Sublobar resection for early-stage lung cancer in high-risk patients: does always the end depends upon the beginning?
    Eur J Cardiothorac Surg. 2024 Jan 9:ezad400. doi: 10.1093.
    PubMed    
    
    
    
57. BOU-SAMRA P, Joffe J, Chang A, Guo E, et al
    Preoperative predictors of successful tumor localization by intraoperative molecular imaging with pafolacianine in lung cancer to create predictive nomogram.
    Eur J Cardiothorac Surg. 2024 Jan 8:ezad392. doi: 10.1093.
    PubMed     Abstract available
    
    
    
58. ETIENNE H, Goudou T, Assouad J
    Atypical mutation of epidermal growth factor receptor in resected stage I non-small-cell lung cancers.
    Eur J Cardiothorac Surg. 2024;65:ezad428.
    PubMed    
    
    
    
59. CHEN T, Wen J, Li Y, Deng J, et al
    Prognostic outcomes and recurrence patterns in resected stage I lung adenocarcinoma harbouring atypical epidermal growth factor receptor mutations.
    Eur J Cardiothorac Surg. 2024;65:ezad388.
    PubMed     Abstract available
    
    
    
60. PETRELLA F, Rossi L, Gatto A, Segramora VM, et al
    Modified transmanubrial approach for complicated type 1 cervical rib resection requiring subclavian artery reconstruction.
    Eur J Cardiothorac Surg. 2024;65:ezae019.
    PubMed     Abstract available
    
    
    December 2023
61. RODRIGUEZ-QUINTERO JH, Kamel MK, Jindani R, Vimolratana M, et al
    Sublobar resection is associated with less lymph nodes examined and lower delivery of adjuvant therapy in patients with 1.5-2.0 cm clinical IA2 non-small cell lung cancer. A retrospective cohort study.
    Eur J Cardiothorac Surg. 2023 Dec 26:ezad431. doi: 10.1093.
    PubMed     Abstract available
    
    
    
62. MARINUCCI BT, Ibrahim M
    The more diagnostic accuracy, the better therapeutic chance: novel insight into lung cancer screening proposal.
    Eur J Cardiothorac Surg. 2023 Dec 13:ezad418. doi: 10.1093.
    PubMed    
    
    
    
63. AL-THANI S, Rahouma M
    A Commentary on Lung Cancer Healthcare Disparities.
    Eur J Cardiothorac Surg. 2023 Dec 12:ezad401. doi: 10.1093.
    PubMed    
    
    
    
64. SONG L, Chen X, Zhu L, Qian G, et al
    Perioperative outcomes of bi-pigtail catheter drainage strategy versus conventional chest tube after uniportal video-assisted thoracic lung surgery.
    Eur J Cardiothorac Surg. 2023;64:ezad411.
    PubMed     Abstract available
    
    
    November 2023
65. TRABALZA MARINUCCI B, Ibrahim M
    Early-stage lung cancer surgery: does the reduction of pulmonary function is really threatening?
    Eur J Cardiothorac Surg. 2023 Nov 25:ezad398. doi: 10.1093.
    PubMed    
    
    
    
66. WANG MM, Li JQ, Dou SH, Li HJ, et al
    Lack of Incremental Value of Three-Dimensional Measurement in Assessing Invasiveness for Lung Cancer.
    Eur J Cardiothorac Surg. 2023 Nov 17:ezad373. doi: 10.1093.
    PubMed     Abstract available
    
    
    
67. RODRIGUEZ-QUINTERO JH, Kamel MK, Jindani R, Zhu R, et al
    "Is Underutilization of Adjuvant Therapy in Resected Non-small Cell Lung Cancer Associated with Socioeconomic Disparities?".
    Eur J Cardiothorac Surg. 2023 Nov 11:ezad383. doi: 10.1093.
    PubMed     Abstract available
    
    
    
68. GUERRERA F, Brunelli A, Falcoz PE, Filosso PL, et al
    Video-Assisted Thoracic Surgery (VATS) or Thoracotomy for Lung Cancer Surgery in Obese Patients? An Analysis of the European Society of Thoracic Surgeons Database.
    Eur J Cardiothorac Surg. 2023 Nov 2:ezad368. doi: 10.1093.
    PubMed     Abstract available
    
    
    
69. PARISSIS H, Baranowski R, McGonigle N
    Navigating uncertainties: recurrence challenges in early-stage non-small-cell adenocarcinoma.
    Eur J Cardiothorac Surg. 2023;64:ezad354.
    PubMed    
    
    
    
70. ZANG N, Shen W, Li S, Chen L, et al
    Sublobar resection reduces the risk of postoperative cognitive dysfunction compared with lobectomy.
    Eur J Cardiothorac Surg. 2023;64:ezad319.
    PubMed     Abstract available
    
    
    
71. WU LL, Lin WK, Qian JY, Ma SS, et al
    Prognostic assessment of lung adenocarcinoma patients with early-staging diseases: a nomogram based on coagulation-related factors.
    Eur J Cardiothorac Surg. 2023;64:ezad313.
    PubMed     Abstract available
    
    
    
72. ZHANG M, Liu X, Ge M
    Prevalence and anatomical characteristics of medial-basal segment in right lung.
    Eur J Cardiothorac Surg. 2023;64:ezad342.
    PubMed     Abstract available
    
    
    
73. TOKER A, Campbell S
    Then comes the robot. In theaters soon.
    Eur J Cardiothorac Surg. 2023;64:ezad379.
    PubMed    
    
    
    October 2023
74. MIYOSHI T, Ito H, Wakabayashi M, Hashimoto T, et al
    Risk factors for loss of pulmonary function after wedge resection for peripheral ground-glass opacity dominant lung cancer.
    Eur J Cardiothorac Surg. 2023 Oct 31:ezad365. doi: 10.1093.
    PubMed     Abstract available
    
    
    
75. US SAQIB HW, Farooqi HA
    The Non-Small-Cell Lung Cancer Crisis: A World-wide Need for Radiomics-Enhanced Early Detection Solutions.
    Eur J Cardiothorac Surg. 2023 Oct 31:ezad367. doi: 10.1093.
    PubMed    
    
    
    
76. KAPLAN T, Keskin UE, Kapan OF, Han S, et al
    Editorial comment correlation between postoperative cognitive dysfunction and the extent of lung resection in lung cancer patients.
    Eur J Cardiothorac Surg. 2023 Oct 27:ezad356. doi: 10.1093.
    PubMed    
    
    
    
77. FLORES R, Patel P P, Taioli E
    Worldwide Lung Cancer Screening initiative-a safe and simple way to reduce deaths.
    Eur J Cardiothorac Surg. 2023 Oct 26:ezad357. doi: 10.1093.
    PubMed    
    
    
    
78. RUSHWAN A, Stefanou D, Tariq J, Drosos P, et al
    Increased minute ventilation to carbon dioxide slope during cardiopulmonary exercise test is associated with poor postoperative outcome following lung cancer resection.
    Eur J Cardiothorac Surg. 2023 Oct 9:ezad337. doi: 10.1093.
    PubMed     Abstract available
    
    
    
79. O'DOWD EL, Tietzova I, Bartlett E, Devaraj A, et al
    ERS/ESTS/ESTRO/ESR/ESTI/EFOMP statement on management of incidental findings from low dose CT screening for lung cancer.
    Eur J Cardiothorac Surg. 2023;64:ezad302.
    PubMed     Abstract available
    
    
    
80. COWEN ME, Gooseman MR
    The role of the diagnostic wedge resection in the era of segmentectomy.
    Eur J Cardiothorac Surg. 2023;64:ezad346.
    PubMed    
    
    
    September 2023
81. FUKUI M, Matsunaga T, Hattori A, Takamochi K, et al
    Sublobar resection is not always superior for early-stage lung cancer with high-risk patients.
    Eur J Cardiothorac Surg. 2023 Sep 26:ezad325. doi: 10.1093.
    PubMed     Abstract available
    
    
    
82. ARMAND E, Fourdrain A, Lafouasse C, Resseguier N, et al
    Is the Epithor conversion score reliable in robotic-assisted surgery anatomical lung resection?
    Eur J Cardiothorac Surg. 2023;64:ezad283.
    PubMed     Abstract available
    
    
    
83. WALLER D, Batchelor T, Wilson H, Stamenkovic S, et al
    Why sacrifice normal lung just for nodal disease in non-small cell lung cancer?
    Eur J Cardiothorac Surg. 2023 Sep 1:ezad298. doi: 10.1093.
    PubMed    
    
    
    July 2023
84. BAO M, Lang Z, Wang Z, Zhang X, et al
    Changes in pulmonary function in lung cancer patients after segmentectomy or lobectomy: a retrospective, non-intervention, observation study.
    Eur J Cardiothorac Surg. 2023 Jul 8:ezad256. doi: 10.1093.
    PubMed     Abstract available
    
    
    
85. SCHLACHTENBERGER G, Schallenberg S, Doerr F, Menghesha H, et al
    Do skip-N2 metastases significantly impact overall survival and disease-free interval in N2 non-small-cell lung cancer patients? A multicentre analysis.
    Eur J Cardiothorac Surg. 2023;64:ezad247.
    PubMed     Abstract available
    
    
    June 2023
86. CAI JS, Li Y, Yang F, Wang X, et al
    Investigation of the non-size determined T4N0-2M0 non-small cell lung cancer: what is the proper T category for the tumor with additional nodules in different lobes of ipsilateral lung?
    Eur J Cardiothorac Surg. 2023 Jun 21:ezad243. doi: 10.1093.
    PubMed     Abstract available
    
    
    
87. PATEL P, Flores R, Alpert N, Pyenson B, et al
    The effect of Stage shift and immunotherapy treatment on lung cancer survival outcomes.
    Eur J Cardiothorac Surg. 2023 Jun 7:ezad203. doi: 10.1093.
    PubMed     Abstract available
    
    
    
88. 
    European society of thoracic surgeons expert consensus recommendations on technical standards of segmentectomy for primary lung cancer.
    Eur J Cardiothorac Surg. 2023 Jun 2:ezad224. doi: 10.1093.
    PubMed    
    
    
    April 2023
89. KIM MS, Hong TH, Yun J, Kim HK, et al
    Lung cancer surgery for patients with reduced left ventricular ejection fraction: clinical outcomes and long-term survival.
    Eur J Cardiothorac Surg. 2023 Apr 26:ezad152. doi: 10.1093.
    PubMed     Abstract available
    
    
    
90. ZHOU H, Yu L
    Sarcopenia is a situation with increasing importance in lung cancer.
    Eur J Cardiothorac Surg. 2023 Apr 11:ezad131. doi: 10.1093.
    PubMed    
    
    
    
91. FOURDRAIN A, Anastay V, Pauly V, Braggio C, et al
    Peripheral location of lung cancer is associated with higher local disease recurrence.
    Eur J Cardiothorac Surg. 2023 Apr 3:ezad130. doi: 10.1093.
    PubMed     Abstract available
    
    
    
92. JIANG T, Tan L
    Pulmonary surgical Apgar score in clinical practice: how far we can go and how we can go further?
    Eur J Cardiothorac Surg. 2023;63:ezad092.
    PubMed    
    
    
    March 2023
93. DING Q, Chen D, Shen S, Wang W, et al
    Clinical profiles and intraoperative identification of complex glands in stage I lung adenocarcinoma.
    Eur J Cardiothorac Surg. 2023;63:ezad073.
    PubMed     Abstract available
    
    
    
94. GKIKAS A, Kakos C, Lampridis S, Godolphin PJ, et al
    Preoperative prognostic factors for 5-year survival following pulmonary metastasectomy from colorectal cancer: a systematic review and meta-analysis.
    Eur J Cardiothorac Surg. 2023;63:ezad059.
    PubMed     Abstract available
    
    
    
95. CAI JS, Yang F, Wang X
    Is there a prognostic difference among patients with T3N0-3M0 non-small-cell lung cancer with different T3 descriptors?
    Eur J Cardiothorac Surg. 2023;63:ezac558.
    PubMed     Abstract available
    
    
    
96. FOURDRAIN A, Thomas PA
    Metachronous ipsilateral lung cancer: reoperate if you can!
    Eur J Cardiothorac Surg. 2023;63:ezad093.
    PubMed    
    
    
    
97. SANZ-SANTOS J, Martinez-Palau M, Jaen A, Rami-Porta R, et al
    Quantitative geometrical measurement of tumour location.
    Eur J Cardiothorac Surg. 2023;63:ezad082.
    PubMed    
    
    
    February 2023
98. GOSSOT D, Lafouasse C, Kovacs E, Seguin-Givelet A, et al
    Sublobar resection for early-stage lung cancer: the issue of safety margins.
    Eur J Cardiothorac Surg. 2023 Feb 22:ezad055. doi: 10.1093.
    PubMed    
    
    
    
99. OKAZAKI M, Suzawa K, Shien K, Yamamoto H, et al
    Surgical outcome of ipsilateral anatomical resection for lung cancer after pulmonary lobectomy.
    Eur J Cardiothorac Surg. 2023 Feb 8:ezad048. doi: 10.1093.
    PubMed     Abstract available
    
    
    
100. HINO H, Hagihira S, Maru N, Utsumi T, et al
     The pulmonary surgical apgar score for lung cancer surgery predicts postoperative complications and long-term survival.
     Eur J Cardiothorac Surg. 2023 Feb 6:ezad036. doi: 10.1093.
     PubMed     Abstract available
     
     
     
101. MUN M, Nakao M, Matsuura Y, Ichinose J, et al
     Prognostic difference between each T3 descriptor in T3N0-3M0 non-small cell lung cancer.
     Eur J Cardiothorac Surg. 2023 Feb 6:ezad037. doi: 10.1093.
     PubMed    
     
     
     
102. AL-THANI S, Rahouma M
     Commentary: sublobar versus lobar resection: further added favourable outcomes in addition to survival.
     Eur J Cardiothorac Surg. 2023;63:ezad054.
     PubMed    
     
     
     
103. HAGEN JA
     Tumor location predicts occult N1 nodal metastases in clinical stage I non-small cell lung cancer: is location alone sufficient to justify limiting the extent of resection.
     Eur J Cardiothorac Surg. 2023 Feb 1:ezad033. doi: 10.1093.
     PubMed    
     
     
     January 2023
104. KAMIGAICHI A, Aokage K, Ikeno T, Wakabayashi M, et al
     Long-term Survival Outcomes after Lobe-specific Nodal Dissection in Patients with Early Non-Small Cell Lung Cancer.
     Eur J Cardiothorac Surg. 2023 Jan 30:ezad016. doi: 10.1093.
     PubMed     Abstract available
     
     
     
105. AKAMINE T, Yotsukura M, Yoshida Y, Nakagawa K, et al
     Feasibility and effectiveness of segmentectomy versus wedge resection for clinical stage I non-small cell lung cancer.
     Eur J Cardiothorac Surg. 2023 Jan 27:ezad018. doi: 10.1093.
     PubMed     Abstract available
     
     
     
106. KAMIGAICHI A, Mimae T, Amioka J, Aoki G, et al
     Segmentectomy preserves better immune-nutritional status than lobectomy in patients with early-stage lung cancer.
     Eur J Cardiothorac Surg. 2023 Jan 24:ezad019. doi: 10.1093.
     PubMed     Abstract available
     
     
     
107. RAO M
     Post-operative Lung Cancer Surveillance: The Highs and Lows of Computerized Tomographic Scanning.
     Eur J Cardiothorac Surg. 2023 Jan 2:ezac593. doi: 10.1093.
     PubMed    
     
     
     December 2022
108. CAO C, Gossot D, Seguin-Givelet A, Melfi F, et al
     Real-world postoperative outcomes of segmentectomy versus lobectomy for lung cancer.
     Eur J Cardiothorac Surg. 2022 Dec 29:ezac571. doi: 10.1093.
     PubMed    
     
     
     
109. KAWAMOTO N, Tsutani Y, Kamigaichi A, Ohsawa M, et al
     Tumour Location Predicts Occult N1 Nodal Metastasis in Clinical Stage I Non-small Cell Lung Cancer.
     Eur J Cardiothorac Surg. 2022 Dec 26:ezac575. doi: 10.1093.
     PubMed     Abstract available
     
     
     
110. MAMMANA M, Sella N, Giraudo C, Verzeletti V, et al
     Postoperative hypoxemic acute respiratory failure after neoadjuvant treatment for lung cancer: radiologic findings and risk factors.
     Eur J Cardiothorac Surg. 2022 Dec 19:ezac569. doi: 10.1093.
     PubMed     Abstract available
     
     
     
111. RAYMOND C, Vieira A, Joubert P, Ugalde PA, et al
     Maximizing Lymph Node Dissection from Fresh Lung Cancer Specimens.
     Eur J Cardiothorac Surg. 2022 Dec 5:ezac554. doi: 10.1093.
     PubMed     Abstract available
     
     
     
112. NAKAMURA A, Hashimoto M, Kondo N, Matsumoto S, et al
     Long-term outcomes and risk factors of residual thoracic spaces after pleurectomy/decortication for mesothelioma.
     Eur J Cardiothorac Surg. 2022;63:ezac500.
     PubMed     Abstract available
     
     
     
113. LE PIMPEC-BARTHES F
     Care management and improvement in understanding the pathophysiological mechanism involved in postoperative residual thoracic spaces after pleurectomy/decortication for mesothelioma.
     Eur J Cardiothorac Surg. 2022;63:ezac557.
     PubMed    
     
     
     
114. MATSUGUMA H, Hasumi K, Wakamatsu I, Nakahara R, et al
     Preoperative diagnosis of sarcopenia and postoperative outcome in patients with non-small-cell lung cancer.
     Eur J Cardiothorac Surg. 2022;63:ezad001.
     PubMed    
     
     
     
115. ARMAND E, Boulate D, Fourdrain A, Nguyen NA, et al
     Benignant and malignant epidemiology among surgical resections for suspicious solitary lung cancer without preoperative tissue diagnosis.
     Eur J Cardiothorac Surg. 2022;63:ezac590.
     PubMed     Abstract available
     
     
     
116. YUTAKA Y, Sato T, Hidaka Y, Kato T, et al
     Electromagnetic navigation bronchoscopy-guided radiofrequency identification marking in wedge resection for fluoroscopically invisible small lung lesions.
     Eur J Cardiothorac Surg. 2022;63:ezad006.
     PubMed     Abstract available
     
     
     
117. MATSUGUMA H, Hasumi K, Wakamatsu I, Nakahara R, et al
     Accurate and patient-friendly intraoperative lung nodule localization method for sublobar resection using a hybrid operating room.
     Eur J Cardiothorac Surg. 2022;63:ezad008.
     PubMed    
     
     
     
118. YANG SM, Chung WY, Ko HJ, Chen LC, et al
     Single-stage augmented fluoroscopic bronchoscopy localization and thoracoscopic resection of small pulmonary nodules in a hybrid operating room.
     Eur J Cardiothorac Surg. 2022;63:ezac541.
     PubMed     Abstract available
     
     
     
119. BAKHUIS W, Kersten CM, Sadeghi AH, Mank QJ, et al
     Preoperative visualization of congenital lung abnormalities: hybridizing artificial intelligence and virtual reality.
     Eur J Cardiothorac Surg. 2022;63:ezad014.
     PubMed     Abstract available
     
     
     November 2022
120. NAKADA T, Takahashi Y, Sakakura N, Masago K, et al
     Postoperative surveillance using low-dose computed tomography for non-small cell lung cancer.
     Eur J Cardiothorac Surg. 2022 Nov 28:ezac549. doi: 10.1093.
     PubMed     Abstract available
     
     
     
121. YAMAGUCHI H, Sato M, Yamamoto K, Shinohara K, et al
     Availability of virtual-assisted lung mapping affects procedure selection for early-stage lung cancer: a web-based cross-sectional study.
     Eur J Cardiothorac Surg. 2022 Nov 23:ezac548. doi: 10.1093.
     PubMed     Abstract available
     
     
     
122. GONZALEZ M, Chriqui LE, Decaluwe H, Aigner C, et al
     Sleeve lobectomy in patients with non-small-cell lung cancer: a report from the European Society of Thoracic Surgery database 2021.
     Eur J Cardiothorac Surg. 2022;62.
     PubMed     Abstract available
     
     
     
123. GOMEZ-HERNANDEZ MT, Forcada C, Varela G, Jimenez MF, et al
     Operating time: an independent and modifiable risk factor for short-term complications after video-thoracoscopic pulmonary lobectomy.
     Eur J Cardiothorac Surg. 2022;62.
     PubMed     Abstract available
     
     
     
124. HAIDARI TA, Bjerrum F, Grimstrup S, Christensen TD, et al
     The left upper lobe challenge in video-assisted thoracoscopic surgery-use of a composite score to improve the assessment of simulated lobectomy.
     Eur J Cardiothorac Surg. 2022;62.
     PubMed     Abstract available
     
     
     
125. ZHANG J, Liu X
     Letter to the editor concerning 'Minimally invasive surgery (MIS) versus thoracotomy for resectable stage II and III non-small-cell lung cancers: a systematic review and meta-analysis' by Shen et al.
     Eur J Cardiothorac Surg. 2022;62.
     PubMed    
     
     
     
126. KITAZUME M, Tane S, Shimizu N, Kitamura Y, et al
     Segmental volumetric analysis with a ventilated or perfused area: identifying the intersegmental plane.
     Eur J Cardiothorac Surg. 2022;62:ezac537.
     PubMed     Abstract available
     
     
     
127. ICHINOSE J, Yamamoto H, Aokage K, Kondo H, et al
     Real-world perioperative outcomes of segmentectomy versus lobectomy for early-stage lung cancer: a propensity score-matched analysis.
     Eur J Cardiothorac Surg. 2022 Nov 2. pii: 6793860. doi: 10.1093.
     PubMed     Abstract available
     
     
     October 2022
128. UEDA D, Tsutani Y, Kamigaichi A, Kawamoto N, et al
     Impact of the Amount of Preoperative Erector Spinae Muscle in Stage I Non-Small Cell Lung Cancer.
     Eur J Cardiothorac Surg. 2022 Oct 31. pii: 6782957. doi: 10.1093.
     PubMed     Abstract available
     
     
     
129. YASUURA Y, Terada Y, Mizuno K, Kayata H, et al
     Quantitative severity of emphysema is related to the prognostic outcome of early-stage lung cancer.
     Eur J Cardiothorac Surg. 2022 Oct 20. pii: 6764596. doi: 10.1093.
     PubMed     Abstract available
     
     
     
130. GOSSOT D, Boddaert G, Mariolo AV, Seguin-Givelet A, et al
     Sublobar resection for early-stage lung cancer: the issue of nodal upstaging.
     Eur J Cardiothorac Surg. 2022 Oct 11. pii: 6758246. doi: 10.1093.
     PubMed    
     
     
     
131. VERZELETTI V, Dell'Amore A, Busetto A, Rea F, et al
     Right tracheal sleeve pneumonectomy for complex pulmonary aspergilloma in a patient with diffuse large B-cell lymphoma.
     Eur J Cardiothorac Surg. 2022;62.
     PubMed     Abstract available
     
     
     
132. MIYATA R, Hamaji M, Kawaguchi A, Shimazu Y, et al
     Epidermal growth factor receptor tyrosine kinase inhibitors as first-line treatment for postoperative recurrent EGFR-mutated lung adenocarcinoma: a multi-institutional retrospective study.
     Eur J Cardiothorac Surg. 2022;62.
     PubMed     Abstract available
     
     
     
133. SPONHOLZ S, Schirren J
     Pulmonary metastasectomy: the discussion continues.
     Eur J Cardiothorac Surg. 2022;62.
     PubMed    
     
     
     
134. WANG Z, Yang F, Zhao X, Mi J, et al
     Outcome of near-infrared fluorescence-navigated pulmonary metastasectomy for hepatocellular carcinoma.
     Eur J Cardiothorac Surg. 2022;62.
     PubMed     Abstract available
     
     
     
135. XU H, Han T, Wang H, Liu S, et al
     Detection of blood stains using computer vision-based algorithms and their association with postoperative outcomes in thoracoscopic lobectomies.
     Eur J Cardiothorac Surg. 2022;62.
     PubMed     Abstract available
     
     
     September 2022
136. WU Y, Song W, Wang Y, Che G, et al
     Consolidation to tumor ratio on computer tomography is not a prognostic factor for non-small cell lung cancer manifesting as radiological part-solid nodules.
     Eur J Cardiothorac Surg. 2022 Sep 30. pii: 6731931. doi: 10.1093.
     PubMed    
     
     
     
137. NAKADA T, Tsukamoto Y, Kato D, Shibazaki T, et al
     Analysis of postoperative weight loss associated with prognosis after lobectomy for lung cancer.
     Eur J Cardiothorac Surg. 2022 Sep 29. pii: 6730746. doi: 10.1093.
     PubMed     Abstract available
     
     
     
138. ISAKA T, Ito H, Yokose T, Saito H, et al
     Impact of segmentectomy and lobectomy on non-lung cancer death in early-stage lung cancer patients.
     Eur J Cardiothorac Surg. 2022 Sep 19. pii: 6705233. doi: 10.1093.
     PubMed     Abstract available
     
     
     
139. LIOU DZ, Chan M, Bhandari P, Lui NS, et al
     Lobar versus sublobar resection in clinical stage IA primary lung cancer with occult N2 disease.
     Eur J Cardiothorac Surg. 2022 Sep 5. pii: 6692306. doi: 10.1093.
     PubMed     Abstract available
     
     
     
140. MAZZELLA A, Spaggiari L
     Invited commentary: indigo carmine and lipiodol mixture marking in lung segmentectomy.
     Eur J Cardiothorac Surg. 2022;62.
     PubMed    
     
     
     
141. MATSUI T, Takahashi Y, Nakada T, Sakakura N, et al
     Preoperative percutaneous needle indigo carmine and lipiodol mixture marking in lung segmentectomy.
     Eur J Cardiothorac Surg. 2022;62.
     PubMed     Abstract available
     
     
     
142. ZENG C, Fu X, Yuan Z, Hu S, et al
     Application of electromagnetic navigation bronchoscopy-guided microwave ablation in multiple pulmonary nodules: a single-centre study.
     Eur J Cardiothorac Surg. 2022;62.
     PubMed     Abstract available
     
     
     August 2022
143. PONCELET AJ, Lacroix V
     Lung Cancer: Is It Node Number Or Node Station?: Pardon Me, But What Is The Question?
     Eur J Cardiothorac Surg. 2022 Aug 10. pii: 6659506. doi: 10.1093.
     PubMed    
     
     
     
144. ZHOU H, Zhu Y, Yan H, Guo H, et al
     What is the proper treatment for visceral pleural invasion in non-small cell lung cancer patients?
     Eur J Cardiothorac Surg. 2022 Aug 4. pii: 6655689. doi: 10.1093.
     PubMed    
     
     
     
145. HUANG L, Frandsen MN, Kehlet H, Petersen RH, et al
     Early and late readmissions after enhanced recovery thoracoscopic lobectomy.
     Eur J Cardiothorac Surg. 2022;62.
     PubMed     Abstract available
     
     
     
146. KAKUTURU J, Toker A
     Hidden usual suspects of video-assisted thoracoscopic surgery lobectomy.
     Eur J Cardiothorac Surg. 2022;62.
     PubMed    
     
     
     
147. BAIG MZ, Razi SS, Agyabeng-Dadzie K, Stroever S, et al
     Robotic-assisted thoracoscopic surgery demonstrates a lower rate of conversion to thoracotomy than video-assisted thoracoscopic surgery for complex lobectomies.
     Eur J Cardiothorac Surg. 2022;62.
     PubMed     Abstract available
     
     
     
148. FOURDRAIN A, Georges O, Gossot D, Falcoz PE, et al
     Patient risk factors for conversion during video-assisted thoracic surgery-the Epithor conversion score.
     Eur J Cardiothorac Surg. 2022;62.
     PubMed     Abstract available
     
     
     
149. THOMAS PA
     Video-assisted thoracic surgery versus stereotactic ablative radiotherapy: is the game over?
     Eur J Cardiothorac Surg. 2022;62.
     PubMed    
     
     
     
150. KAISER LR
     Ground-glass opacity component in semi-solid lesions: how much is enough?
     Eur J Cardiothorac Surg. 2022;62.
     PubMed    
     
     
     
151. POMPILI C
     What my life will be like after surgery?
     Eur J Cardiothorac Surg. 2022;62.
     PubMed    
     
     
     
152. DECALUWE H, Van Raemdonck D
     The bubble in predicting bubbles?
     Eur J Cardiothorac Surg. 2022;62.
     PubMed    
     
     
     
153. BACIEWICZ FA
     Everybody knows that smokin' ain't allowed (in school) before lung surgery!
     Eur J Cardiothorac Surg. 2022;62.
     PubMed    
     
     
     
154. HUANG L, Frandsen MN, Kehlet H, Petersen RH, et al
     Days alive and out of hospital after enhanced recovery video-assisted thoracoscopic surgery lobectomy.
     Eur J Cardiothorac Surg. 2022;62.
     PubMed     Abstract available
     
     
     
155. GONZALEZ M, Karenovics W, Bedat B, Forster C, et al
     Performance of prolonged air leak scoring systems in patients undergoing video-assisted thoracoscopic surgery segmentectomy.
     Eur J Cardiothorac Surg. 2022;62.
     PubMed     Abstract available
     
     
     
156. TAKEDA A, Ueda K, Aoki M, Nagata T, et al
     Altered lymphatic structure and function in pleural anthracosis: negative role in skip N2 metastasis.
     Eur J Cardiothorac Surg. 2022;62.
     PubMed     Abstract available
     
     
     July 2022
157. BOLUKBAS S, Baldes N, Hoda MA, Eberlein M, et al
     Multimodality treatment of malignant pleural mesothelioma: evolving patient selection criteria using scores.
     Eur J Cardiothorac Surg. 2022;62.
     PubMed    
     
     
     
158. GREB D, Hebeisen M, Matter A, Opitz I, et al
     Prospective validation and extension of the Multimodality Prognostic Score for the treatment allocation of pleural mesothelioma patients.
     Eur J Cardiothorac Surg. 2022;62.
     PubMed     Abstract available
     
     
     
159. SCHLACHTENBERGER G, Doerr F, Menghesha H, Heldwein MB, et al
     Pulmonary metastasectomy for metastatic head and neck cancer prolongs survival significantly compared to non-surgical therapy.
     Eur J Cardiothorac Surg. 2022;62.
     PubMed     Abstract available
     
     
     
160. YANG Z, Wang Y, Chen Y, Qian F, et al
     Combined large cell neuroendocrine carcinoma: clinical characteristics, prognosis and postoperative management.
     Eur J Cardiothorac Surg. 2022;62.
     PubMed     Abstract available
     
     
     
161. KAMIGAICHI A, Aokage K, Katsumata S, Ishii G, et al
     Prognostic Impact of Examined Mediastinal Lymph Node Count in Clinical N0 Non-Small Cell Lung Cancer.
     Eur J Cardiothorac Surg. 2022 Jul 4. pii: 6628585. doi: 10.1093.
     PubMed     Abstract available
     
     
     June 2022
162. PONS A, De Sousa P, Proli C, Booth SA, et al
     Impact of society and national guidelines on patient selection for lung cancer surgery in the United Kingdom.
     Eur J Cardiothorac Surg. 2022 Jun 29. pii: 6619559. doi: 10.1093.
     PubMed     Abstract available
     
     
     
163. DE RUITER JC, Smit EF, van der Noort V, Hartemink KJ, et al
     Reply to Peng et al.
     Eur J Cardiothorac Surg. 2022;62.
     PubMed    
     
     
     
164. WILLIAMS NR, Patrick H, Fiorentino F, Allen A, et al
     Pulmonary Metastasectomy in Colorectal Cancer (PulMiCC) randomized controlled trial: a systematic review of published responses.
     Eur J Cardiothorac Surg. 2022;62.
     PubMed     Abstract available
     
     
     
165. TAKAMORI S, Oizumi H, Suzuki J, Watanabe H, et al
     Thoracoscopic anatomical individual basilar segmentectomy.
     Eur J Cardiothorac Surg. 2022;62.
     PubMed     Abstract available
     
     
     
166. SOH J, Toyooka S, Shintani Y, Okami J, et al
     Limited resection for stage IA radiologically invasive lung cancer: a real-world nationwide database study.
     Eur J Cardiothorac Surg. 2022 Jun 9. pii: 6604739. doi: 10.1093.
     PubMed     Abstract available
     
     
     May 2022
167. PENG L, Deng HY, Wang Y
     Surgery should still remain the prior option for treating operable early-stage non-small cell lung cancer.
     Eur J Cardiothorac Surg. 2022 May 28. pii: 6594489. doi: 10.1093.
     PubMed    
     
     
     
168. DAFFRE E, Prieto M, Maiolino E, Alifano M, et al
     Spreading through airspaces: should its existence play a role in thinking about lung metastases?
     Eur J Cardiothorac Surg. 2022;61:1249-1250.
     PubMed    
     
     
     
169. IGAI H, Matsuura N, Kamiyoshihara M
     Infrared thoracoscopic pulmonary segmentectomy with intravenous indocyanine green administration using preoperative simulation.
     Eur J Cardiothorac Surg. 2022;61:1443-1445.
     PubMed     Abstract available
     
     
     
170. MA Y, Zhang Y, Li H, Li J, et al
     Spread through air spaces is a common phenomenon of pulmonary metastasized tumours regardless of origins.
     Eur J Cardiothorac Surg. 2022;61:1242-1248.
     PubMed     Abstract available
     
     
     
171. IGAI H, Matsuura N, Kamiyoshihara M
     Invited commentary on: The usefulness of the nomogram to predict tumor spread through air spaces (STAS) in patients with clinical stage I non-small cell lung cancer preoperatively.
     Eur J Cardiothorac Surg. 2022 May 13. pii: 6585338. doi: 10.1093.
     PubMed    
     
     
     
172. MERCIER O
     VATS vs. Open Thoracotomy for lung cancer resection: is the game still running?
     Eur J Cardiothorac Surg. 2022 May 11. pii: 6584011. doi: 10.1093.
     PubMed    
     
     
     
173. MA Z, Wang S, Zhu H, Li Y, et al
     Comprehensive Investigation of Lung Cancer Associated with Cystic Airspaces: Predictive Value of Morphology.
     Eur J Cardiothorac Surg. 2022 May 4. pii: 6580206. doi: 10.1093.
     PubMed     Abstract available
     
     
     
174. VARELA G
     Do not try to run before you can walk.
     Eur J Cardiothorac Surg. 2022;61:1030.
     PubMed    
     
     
     April 2022
175. MATSUO S, Kanauchi N, Satou K, Uchida T, et al
     A surgical case: patient with left lower lobe lung cancer with a common trunk in the inferior pulmonary vein.
     Eur J Cardiothorac Surg. 2022 Apr 20. pii: 6571146. doi: 10.1093.
     PubMed    
     
     
     
176. HEALY DG
     The visceral pleura, lung cancer and lymphatic spread.
     Eur J Cardiothorac Surg. 2022 Apr 19. pii: 6570167. doi: 10.1093.
     PubMed    
     
     
     
177. WANG YF, Deng HY, Huang W, Zhou Q, et al
     Segmentectomy for early-stage non-small-cell lung cancer with invasive characteristics: the definitions of invasiveness and feasibility of segmentectomy.
     Eur J Cardiothorac Surg. 2022 Apr 9. pii: 6565839. doi: 10.1093.
     PubMed    
     
     
     
178. DING Y, Chen Y, Wen H, Li J, et al
     Pretreatment prediction of tumour spread through air spaces in clinical stage I non-small cell lung cancer.
     Eur J Cardiothorac Surg. 2022 Apr 6. pii: 6564227. doi: 10.1093.
     PubMed     Abstract available
     
     
     March 2022
179. DE RUITER JC, van Diessen JNA, Smit EF, van der Noort V, et al
     Minimally invasive lobectomy versus stereotactic ablative radiotherapy for stage I non-small cell lung cancer.
     Eur J Cardiothorac Surg. 2022 Mar 28. pii: 6554916. doi: 10.1093.
     PubMed     Abstract available
     
     
     
180. KUDO Y, Shimada Y, Matsubayashi J, Kitamura Y, et al
     Artificial intelligence analysis of three-dimensional imaging data derives factors associated with postoperative recurrence in patients with radiologically solid-predominant small-sized lung cancers.
     Eur J Cardiothorac Surg. 2022;61:751-760.
     PubMed     Abstract available
     
     
     
181. HATTORI A, Matsunaga T, Fukui M, Takamochi K, et al
     Prognosis of epidermal growth factor receptor-mutated stage I lung adenocarcinoma with radiologically solid features.
     Eur J Cardiothorac Surg. 2022;61:769-777.
     PubMed     Abstract available
     
     
     
182. YAMAGUCHI H, Sato M, Yamamoto K, Ueda K, et al
     Virtual-assisted lung mapping in sublobar resection of small pulmonary nodules, long-term results.
     Eur J Cardiothorac Surg. 2022;61:761-768.
     PubMed     Abstract available
     
     
     
183. KAMIGAICHI A, Tsutani Y, Mimae T, Miyata Y, et al
     The prognostic impact of the ground-glass opacity component in nearly pure-solid stage IA non-small-cell lung cancer.
     Eur J Cardiothorac Surg. 2022 Mar 16. pii: 6549206. doi: 10.1093.
     PubMed     Abstract available
     
     
     
184. KADOMATSU Y, Sugiyama T, Sato K, Nakanishi K, et al
     Relationship of smoking cessation period with the incidence of complications in lung cancer surgery.
     Eur J Cardiothorac Surg. 2022 Mar 10. pii: 6546233. doi: 10.1093.
     PubMed     Abstract available
     
     
     
185. KAPETANAKIS EI, Tomos IP, Schizas D, Caimmi PP, et al
     Seeking Aristotle's 'golden mean' in lung cancer resection surgery.
     Eur J Cardiothorac Surg. 2022 Mar 9. pii: 6545819. doi: 10.1093.
     PubMed    
     
     
     February 2022
186. RECUERO-DIAZ JL, Royo-Crespo I, Gomez de-Antonio D, Call S, et al
     Treatment and intention-to-treat propensity score analysis to evaluate the impact of video-assisted thoracic surgery on 90-day mortality after anatomical resection for lung cancer.
     Eur J Cardiothorac Surg. 2022 Feb 25. pii: 6537078. doi: 10.1093.
     PubMed     Abstract available
     
     
     
187. KAGIMOTO A, Tsutani Y, Shimada Y, Mimae T, et al
     Oncological outcome of segmentectomy for early-stage non-small-cell lung cancer with invasive characteristics: a multicentre study.
     Eur J Cardiothorac Surg. 2022 Feb 12. pii: 6527517. doi: 10.1093.
     PubMed     Abstract available
     
     
     
188. RABINEL P, Verge R, Cazaux M, Mazzoni L, et al
     Predictive factors and prognosis of microscopic residual disease in non-small-cell lung cancer surgery.
     Eur J Cardiothorac Surg. 2022 Feb 11. pii: 6527003. doi: 10.1093.
     PubMed     Abstract available
     
     
     January 2022
189. CHAN JWY, Lau RWH, Ng CSH
     Splitting hairs or not: importance of N2 subclassification after neoadjuvant treatment and surgery.
     Eur J Cardiothorac Surg. 2022;61:277-278.
     PubMed    
     
     
     
190. HATTORI A, Matsunaga T, Fukui M, Takamochi K, et al
     Prognostic influence of a ground-glass opacity component in hypermetabolic lung adenocarcinoma.
     Eur J Cardiothorac Surg. 2022;61:249-256.
     PubMed     Abstract available
     
     
     
191. GOMEZ-HERNANDEZ MT, Fuentes MG, Novoa NM, Rodriguez I, et al
     The robotic surgery learning curve of a surgeon experienced in video-assisted thoracoscopic surgery compared with his own video-assisted thoracoscopic surgery learning curve for anatomical lung resections.
     Eur J Cardiothorac Surg. 2022;61:289-296.
     PubMed     Abstract available
     
     
     
192. ZHANG C, Li J, Sun H, Liu H, et al
     An aberrant anterior ascending segmental pulmonary artery (A3aii) in a patient with lung cancer.
     Eur J Cardiothorac Surg. 2022 Jan 8. pii: 6501291. doi: 10.1093.
     PubMed     Abstract available
     
     
     December 2021
193. PETERSEN RH
     Is complex segmentectomy safe?
     Eur J Cardiothorac Surg. 2021;61:108-109.
     PubMed    
     
     
     
194. HATTORI A, Takamochi K, Shiono S, Tsuboi M, et al
     Multicentre prospective observational study for pulmonary vein stump thrombus after anatomical lung resections.
     Eur J Cardiothorac Surg. 2021;61:92-99.
     PubMed     Abstract available
     
     
     
195. OKUBO Y, Yoshida Y, Yotsukura M, Nakagawa K, et al
     Complex segmentectomy is not a complex procedure relative to simple segmentectomy.
     Eur J Cardiothorac Surg. 2021;61:100-107.
     PubMed     Abstract available
     
     
     November 2021
196. DRAWBERT HE, Hey MT, Tarrazzi F, Block M, et al
     Early discharge on postoperative day 1 following lobectomy for stage I non-small-cell lung cancer is safe in high-volume surgical centres: a national cancer database analysis.
     Eur J Cardiothorac Surg. 2021 Nov 29. pii: 6445266. doi: 10.1093.
     PubMed     Abstract available
     
     
     
197. WIGHTMAN SC, Lee JY, Ding L, Atay SM, et al
     Adjuvant chemotherapy for visceral pleural invasion in 3-4-cm non-small-cell lung cancer improves survival.
     Eur J Cardiothorac Surg. 2021 Nov 22. pii: 6433261. doi: 10.1093.
     PubMed     Abstract available
     
     
     
198. WANG Y, Zhong C, Fang W
     Thoracoscopic segmentectomy for early-stage non-small cell lung cancer: are we doing the right thing for our patients?
     Eur J Cardiothorac Surg. 2021 Nov 11. pii: 6425615. doi: 10.1093.
     PubMed    
     
     
     
199. MATSUGUMA H, Hasumi K, Wakamatsu I, Nakahara R, et al
     Segmentectomy versus lobectomy for solid predominant cN0 lung cancer considering Deauville score.
     Eur J Cardiothorac Surg. 2021 Nov 11. pii: 6425616. doi: 10.1093.
     PubMed    
     
     
     
200. GRYSZKO GM, Cackowski MM, Zbytniewski M, Woznica K, et al
     The impact of left lower paratracheal (4L) lymph node dissection on survival in patients with surgically treated left-sided NSCLC.
     Eur J Cardiothorac Surg. 2021;60:1201-1209.
     PubMed     Abstract available
     
     
     
201. DENG C, Zhang Y, Fu F, Ma X, et al
     Genetic-pathological prediction for timing and site-specific recurrence pattern in resected lung adenocarcinoma.
     Eur J Cardiothorac Surg. 2021;60:1223-1231.
     PubMed     Abstract available
     
     
     
202. CABANERO A, Cavestany C, Fra S, Munoz G, et al
     Mediastinal lymph node dissection: punishment or discipline?
     Eur J Cardiothorac Surg. 2021;60:1242-1243.
     PubMed    
     
     
     October 2021
203. ISAKA T, Ito H, Nakayama H, Yokose T, et al
     Impact of the initial site of recurrence on prognosis after curative surgery for primary lung cancer.
     Eur J Cardiothorac Surg. 2021 Oct 23. pii: 6408981. doi: 10.1093.
     PubMed     Abstract available
     
     
     
204. XU L, Yan HJ, Tian D
     Prediction model of lymph node metastases for lung adenocarcinoma: increased applicability of this modeldouble dagger.
     Eur J Cardiothorac Surg. 2021;60:1007-1008.
     PubMed    
     
     
     
205. KAGIMOTO A, Tsutani Y, Mimae T, Miyata Y, et al
     Segmentectomy versus lobectomy for solid predominant cN0 lung cancer: analysis using visual evaluation of positron emission tomography.
     Eur J Cardiothorac Surg. 2021 Oct 14. pii: 6396284. doi: 10.1093.
     PubMed     Abstract available
     
     
     
206. DELL'AMORE A, Lomangino I, Cannone G, Terzi S, et al
     Comparison of operative and postoperative characteristics and outcomes between thoracoscopic segmentectomy and lobectomy for non-small-cell lung cancer: a propensity score matching study from the Italian VATS Group Registry.
     Eur J Cardiothorac Surg. 2021 Oct 13. pii: 6395268. doi: 10.1093.
     PubMed     Abstract available
     
     
     September 2021
207. GOSSOT D
     Lobar or sublobar resection for early-stage lung cancer: at the crossroads.
     Eur J Cardiothorac Surg. 2021 Sep 21. pii: 6373496. doi: 10.1093.
     PubMed    
     
     
     
208. TANE S, Nishikubo M, Kitazume M, Fujibayashi Y, et al
     Cluster analysis of emphysema for predicting pulmonary complications after thoracoscopic lobectomy.
     Eur J Cardiothorac Surg. 2021;60:607-613.
     PubMed     Abstract available
     
     
     August 2021
209. MENNECIER B, Olland A, Mascaux C, Falcoz PE, et al
     Re: Two centres' experience with lung cancer resection in patients with advanced non-small-cell lung cancer following treatment with immune checkpoint inhibitors: safety and clinical outcomes.
     Eur J Cardiothorac Surg. 2021 Aug 26. pii: 6357858. doi: 10.1093.
     PubMed    
     
     
     
210. HOEIJMAKERS F, Hartemink KJ, Verhagen AF, Steup WH, et al
     Variation in incidence, prevention and treatment of persistent air leak after lung cancer surgery.
     Eur J Cardiothorac Surg. 2021 Aug 19. pii: 6354830. doi: 10.1093.
     PubMed     Abstract available
     
     
     
211. FALCOZ PE
     The prognostic value of lymph node ratio in patients with surgically resected stage I-III small-cell lung cancer: a propensity score matching analysis of the SEER database.
     Eur J Cardiothorac Surg. 2021 Aug 11. pii: 6348064. doi: 10.1093.
     PubMed    
     
     
     
212. LUCCHI M, Aprile V
     Not one less, the role of 4L in left-sided lung cancer: the message from the Polish experience.
     Eur J Cardiothorac Surg. 2021 Aug 11. pii: 6348067. doi: 10.1093.
     PubMed    
     
     
     
213. STAMATIS G, Muller S, Weinreich G, Schwarz B, et al
     Significantly favourable outcome for patients with non-small-cell lung cancer stage IIIA/IIIB and single-station persistent N2 (skip or additionally N1) disease after multimodality treatment.
     Eur J Cardiothorac Surg. 2021 Aug 9. pii: 6345854. doi: 10.1093.
     PubMed     Abstract available
     
     
     
214. MERCIER O, Barlesi F
     Precision follow-up for resected non-small-cell lung cancer: is it ready for prime time?
     Eur J Cardiothorac Surg. 2021 Aug 4. pii: 6339783. doi: 10.1093.
     PubMed    
     
     
     
215. HELMINEN O, Soderstrom J, Andersen H, Sihvo E, et al
     How often segmentectomy is feasible in lung cancer surgery: a population-based evaluation.
     Eur J Cardiothorac Surg. 2021 Aug 4. pii: 6339790. doi: 10.1093.
     PubMed     Abstract available
     
     
     July 2021
216. BEATTIE R, Furrer K, Dolan DP, Curioni-Fontecedro A, et al
     Two centres experience of lung cancer resection in patients with advanced non-small cell lung cancer upon treatment with immune checkpoint inhibitors: safety and clinical outcomes.
     Eur J Cardiothorac Surg. 2021 Jul 31. pii: 6332634. doi: 10.1093.
     PubMed     Abstract available
     
     
     
217. XU ZJ, Lin YD
     Reply to Zhang et al.
     Eur J Cardiothorac Surg. 2021;60:440.
     PubMed    
     
     
     
218. KITAHARA H, Shoji F, Akamine T, Kinoshita F, et al
     Preoperative prognostic nutritional index level is associated with tumour-infiltrating lymphocyte status in patients with surgically resected lung squamous cell carcinoma.
     Eur J Cardiothorac Surg. 2021;60:393-401.
     PubMed     Abstract available
     
     
     
219. JONES DR
     Neoadjuvant immunochemotherapy in surgically resectable non-small-cell lung cancer: surgical expertise required.
     Eur J Cardiothorac Surg. 2021;60:88-90.
     PubMed    
     
     
     
220. BERTOLACCINI L, Spaggiari L
     The land of the Lotus-eaters in the COVID-19 epidemic.
     Eur J Cardiothorac Surg. 2021;60:1-2.
     PubMed    
     
     
     
221. GOOSEMAN MR, Falcoz PE, Decaluwe H, Szanto Z, et al
     Morbidity and mortality of lung resection candidates defined by the American College of Chest Physicians as 'moderate risk': an analysis from the European Society of Thoracic Surgeons database.
     Eur J Cardiothorac Surg. 2021;60:91-97.
     PubMed     Abstract available
     
     
     
222. AOKAGE K, Suzuki K, Wakabayashi M, Mizutani T, et al
     Predicting pathological lymph node status in clinical stage IA peripheral lung adenocarcinoma.
     Eur J Cardiothorac Surg. 2021;60:64-71.
     PubMed     Abstract available
     
     
     
223. CHENESSEAU J, Mitilian D, Sharma G, Mussot S, et al
     Superior vena cava prosthetic replacement for non-small cell lung cancer: is it worthwhile?
     Eur J Cardiothorac Surg. 2021 Jul 1. pii: 6312872. doi: 10.1093.
     PubMed     Abstract available
     
     
     
224. YANG H, Mei T
     The prognostic value of lymph node ratio in patients with surgically resected stage I-III small-cell lung cancer: a propensity score matching analysis of the SEER database.
     Eur J Cardiothorac Surg. 2021 Jul 1. pii: 6311990. doi: 10.1093.
     PubMed     Abstract available
     
     
     June 2021
225. NOJIRI T, Inoue M, Maeda H, Takeuchi Y, et al
     Retraction to 'Low-dose human atrial natriuretic peptide for the prevention of postoperative cardiopulmonary complications in chronic obstructive pulmonary disease patients undergoing lung cancer surgery'.
     Eur J Cardiothorac Surg. 2021;59:1352.
     PubMed    
     
     
     
226. MARIANI AW, Vallilo CC, de Albuquerque ALP, Salge JM, et al
     Preoperative evaluation for lung resection in patients with bronchiectasis: should we rely on standard lung function evaluation?
     Eur J Cardiothorac Surg. 2021;59:1272-1278.
     PubMed     Abstract available
     
     
     
227. ZHAO M, Deng J, Wang T, Li Y, et al
     Impact of computed tomography window settings on clinical T classifications and prognostic evaluation of patients with subsolid nodules.
     Eur J Cardiothorac Surg. 2021;59:1295-1303.
     PubMed     Abstract available
     
     
     
228. FALCOZ PE, Olland A, Charloux A
     Does functional evaluation before lung cancer surgery need reappraisal?
     Eur J Cardiothorac Surg. 2021 Jun 11. pii: 6296136. doi: 10.1093.
     PubMed    
     
     
     May 2021
229. XIE D, Zhong Y, Deng J, She Y, et al
     Comparison of uniportal video-assisted thoracoscopic versus thoracotomy bronchial sleeve lobectomy with pulmonary arterioplasty for centrally located non-small-cell lung cancer.
     Eur J Cardiothorac Surg. 2021;59:978-986.
     PubMed     Abstract available
     
     
     
230. SHEN H, Wang X, Nie Y, Zhang K, et al
     Minimally invasive surgery versus thoracotomy for resectable stage II and III non-small-cell lung cancers: a systematic review and meta-analysis.
     Eur J Cardiothorac Surg. 2021;59:940-950.
     PubMed     Abstract available
     
     
     
231. GONZALEZ M, Brunelli A, Szanto Z, Passani S, et al
     Report from the European Society of Thoracic Surgeons database 2019: current surgical practice and perioperative outcomes of pulmonary metastasectomy.
     Eur J Cardiothorac Surg. 2021;59:996-1003.
     PubMed     Abstract available
     
     
     April 2021
232. KAMIGAICHI A, Tsutani Y, Okada M
     Reply to Zhang et al.
     Eur J Cardiothorac Surg. 2021;59:928.
     PubMed    
     
     
     
233. CASIRAGHI M, Spaggiari L
     Reply to Lampridis.
     Eur J Cardiothorac Surg. 2021;59:926-927.
     PubMed    
     
     
     
234. NAKAGAWA K
     Reply to Ding et al.
     Eur J Cardiothorac Surg. 2021;59:925-926.
     PubMed    
     
     
     
235. KANZAKI R, Nagoya A, Kanou T, Ose N, et al
     Risk factors for non-cancer death after surgery in patients with stage I non-small-cell lung cancer.
     Eur J Cardiothorac Surg. 2021;59:633-640.
     PubMed     Abstract available
     
     
     
236. VAN RAEMDONCK D, Treasure T, Van Cutsem E, Macbeth F, et al
     Pulmonary Metastasectomy in Colorectal Cancer: has the randomized controlled trial brought enough reliable evidence to convince believers in metastasectomy to reconsider their oncological practice?
     Eur J Cardiothorac Surg. 2021;59:517-521.
     PubMed    
     
     
     
237. WANG Z, Yang H, Hao X, Zhou J, et al
     Prognostic significance of the N1 classification pattern: a meta-analysis of different subclassification methods.
     Eur J Cardiothorac Surg. 2021;59:545-553.
     PubMed     Abstract available
     
     
     
238. XIE D, Wu J, Hu X, Gonzalez-Rivas D, et al
     Uniportal versus multiportal video-assisted thoracoscopic surgery does not compromise the outcome of segmentectomy.
     Eur J Cardiothorac Surg. 2021;59:650-657.
     PubMed     Abstract available
     
     
     
239. ZHONG Y, Xu Y, Deng J, Wang T, et al
     Prognostic impact of tumour spread through air space in radiological subsolid and pure solid lung adenocarcinoma.
     Eur J Cardiothorac Surg. 2021;59:624-632.
     PubMed     Abstract available
     
     
     January 2021
240. PETERSEN RH, Huang L, Kehlet H
     Guidelines for enhanced recovery after lung surgery: need for re-analysis.
     Eur J Cardiothorac Surg. 2021;59:291-292.
     PubMed    
     
     
     
241. WALLER DA, Opitz I, Bueno R, Van Schil P, et al
     Divided by an ocean of water but united in an ocean of uncertainty: a transatlantic review of mesothelioma surgery guidelines.
     Eur J Cardiothorac Surg. 2021;59:8-11.
     PubMed    
     
     
     September 2020
242. NA KJ, Park S, Lee HJ, Park IK, et al
     Comparison between lung perfusion scan and single-photon emission computed tomography/computed tomography for predicting postoperative lung function after pulmonary resection in patients with borderline lung function.
     Eur J Cardiothorac Surg. 2020 Sep 3. pii: 5900864. doi: 10.1093.
     PubMed     Abstract available
     
     
     September 2019
243. CHEN C, Zhang X, Gu C, Wang Y, et al
     Surgery performed at night by continuously working surgeons contributes to a higher incidence of intraoperative complications in video-assisted thoracoscopic pulmonary resection: a large monocentric retrospective study.
     Eur J Cardiothorac Surg. 2019 Sep 20. pii: 5572143. doi: 10.1093.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Lung Cancer is free of charge.